US2006088607A1PendingUtilityA1

Nutritional supplement compositions

52
Assignee: STEFANO GEORGE BPriority: Oct 1, 2004Filed: Sep 30, 2005Published: Apr 27, 2006
Est. expiryOct 1, 2024(expired)· nominal 20-yr term from priority
Inventors:George B. StefanoPatrick CadetKirk J. MantioneWei Zhu
A61P 43/00A61P 9/10A61P 25/22A61P 25/00A61P 29/00A61P 25/18A61P 25/16A61P 25/24A61P 25/30A61P 25/28A61K 33/06A23L 33/10A61K 45/06A61P 17/00A61K 31/485A61K 31/472A61K 31/194A23V 2002/00A61K 33/04A61K 31/198A61K 31/7052A61P 19/02
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Dietary supplement compositions containing one or more compounds such as arginine, selenium, calcium, calcium sources, morphine precursors (e.g., reticuline), morphine, and morphine-6β-glucuronide are provided.

Claims

exact text as granted — not AI-modified
1 . A dietary supplement composition comprising morphine or morphine-6β-glucuronide in an amount that results in less than  0 . 05  mg of said morphine or morphine-6β-glucuronide being administered to a human per kg of body weight of said human.  
     
     
         2 . The composition of  claim 1 , wherein said composition comprises less than 4.0 mg of said morphine or morphine-6β-glucuronide.  
     
     
         3 . The composition of  claim 1 , wherein said composition comprises less than 1.0 mg of said morphine or morphine-6β-glucuronide.  
     
     
         4 . The composition of  claim 1 , wherein said composition comprises a morphine precursor.  
     
     
         5 . The composition of  claim 1 , wherein said composition is in the form of a tablet.  
     
     
         6 . The composition of  claim 1 , wherein said composition comprises selenium.  
     
     
         7 . The composition of  claim 1 , wherein said composition comprises L-arginine.  
     
     
         8 . The composition of  claim 1 , wherein said composition comprises a calcium source.  
     
     
         9 . The composition of  claim 1 , wherein said morphine or morphine-6β-glucuronide is in an amount that results in less than 0.025 mg of said morphine or morphine-6β-glucuronide being administered to said human per kg of body weight of said human.  
     
     
         10 . The composition of  claim 1 , wherein said morphine or morphine-6β-glucuronide is in an amount that results in less than 0.01 mg of said morphine or morphine-6β-glucuronide being administered to said human per kg of body weight of said human.  
     
     
         11 . The composition of  claim 1 , wherein said composition comprises morphine.  
     
     
         12 . The composition of  claim 1 , wherein said composition comprises morphine and morphine-6β-glucuronide.  
     
     
         13 . The composition of  claim 1 , wherein said composition comprises thebaine, codeine, reticuline, norlaudanosoline, salutaridine, dopamine, L-DOPA, tyrosine, tyramine, phenylalanine, 3,4 dihydroxyphenyl pyruvate, or dihydroxyphenyl acetaldehyde.  
     
     
         14 . A dietary supplement composition comprising morphine and a compound selected from the group consisting of selenium and arginine.  
     
     
         15   15 . The composition of  claim 14 , wherein said composition comprises between 35 μg and 700 μg of morphine.  
     
     
         16 . The composition of  claim 14 , wherein said composition comprises between 55 μg and 300 μg of selenium.  
     
     
         17 . The composition of  claim 14 , wherein said composition comprises between 1 mg and 500 mg of arginine.  
     
     
         18 . The composition of  claim 14 , wherein said composition comprises a calcium source.  
     
     
         19 . The composition of  claim 18 , wherein said composition comprises between 1 g and 1.3 g of said calcium source.  
     
     
         20 . The composition of  claim 18 , wherein said calcium source is calcium citrate.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.